BRIEF-Organon Announces US FDA Approval Of Supplemental New Drug Application Extending Duration Of Use Of Nexplanon® 68 Mg Radiopaque

Reuters01-17

Jan 16 (Reuters) - Organon & Co OGN.N:

ORGANON ANNOUNCES US FOOD AND DRUG ADMINISTRATION APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION EXTENDING DURATION OF USE OF NEXPLANON® (ETONOGESTREL IMPLANT) 68 MG RADIOPAQUE
ORGANON & CO - NEXPLANON USE EXTENDED TO FIVE YEARS

Source text: ID:nBw6MtY47a

Further company coverage: OGN.N

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2604571948?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-17 10:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2604571948","market":"fut","top_or_hot":-1,"title":"BRIEF-Organon Announces US FDA Approval Of Supplemental New Drug Application Extending Duration Of Use Of Nexplanon® 68 Mg Radiopaque","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Organon Announces US FDA Approval Of Supplemental New Drug Application Extending Duration Of Use Of Nexplanon® 68 Mg Radiopaque</title></head><body><p><span>Jan 16 (Reuters)</span><span> - </span>Organon &amp; Co <span>OGN.N</span>:</p><ul><li><p>ORGANON ANNOUNCES US FOOD AND DRUG ADMINISTRATION APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION EXTENDING DURATION OF USE OF NEXPLANON® (ETONOGESTREL IMPLANT) 68 MG RADIOPAQUE</p></li><li><p>ORGANON &amp; CO - NEXPLANON USE EXTENDED TO FIVE YEARS</p></li></ul><p>Source text: <span>ID:nBw6MtY47a</span></p><p>Further company coverage: <span>OGN.N</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Organon Announces US FDA Approval Of Supplemental New Drug Application Extending Duration Of Use Of Nexplanon® 68 Mg Radiopaque</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Organon Announces US FDA Approval Of Supplemental New Drug Application Extending Duration Of Use Of Nexplanon® 68 Mg Radiopaque\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-17 10:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Organon Announces US FDA Approval Of Supplemental New Drug Application Extending Duration Of Use Of Nexplanon® 68 Mg Radiopaque</title></head><body><p><span>Jan 16 (Reuters)</span><span> - </span>Organon &amp; Co <span>OGN.N</span>:</p><ul><li><p>ORGANON ANNOUNCES US FOOD AND DRUG ADMINISTRATION APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION EXTENDING DURATION OF USE OF NEXPLANON® (ETONOGESTREL IMPLANT) 68 MG RADIOPAQUE</p></li><li><p>ORGANON &amp; CO - NEXPLANON USE EXTENDED TO FIVE YEARS</p></li></ul><p>Source text: <span>ID:nBw6MtY47a</span></p><p>Further company coverage: <span>OGN.N</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4559","symbol_name":"巴菲特持仓","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260117:nTUA4YPDVN:1","article_id":"2604571948","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2604571948","pubTimestamp":1768616095,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Organon Announces US FDA Approval Of Supplemental New Drug Application Extending Duration Of Use Of Nexplanon 68 Mg RadiopaqueJan 16 (Reuters) - Organon & Co OGN.N:ORGANON ANNOUNCES US FOOD AND ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4559":"巴菲特持仓","OGN":"Organon & Co","LU2065170008.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC","BK4588":"碎股","LU2065171311.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","BK4585":"ETF&股票定投概念","BK4007":"制药","LU2065169927.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) ACC","LU2065171402.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) INC"},"translate_title":"简报-Organon宣布美国FDA批准延长Nexplanon使用期限的补充新药申请®68毫克不透射线","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OGN":0.9},"content_text":"BRIEF-Organon Announces US FDA Approval Of Supplemental New Drug Application Extending Duration Of Use Of Nexplanon® 68 Mg RadiopaqueJan 16 (Reuters) - Organon & Co OGN.N:ORGANON ANNOUNCES US FOOD AND DRUG ADMINISTRATION APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION EXTENDING DURATION OF USE OF NEXPLANON® (ETONOGESTREL IMPLANT) 68 MG RADIOPAQUEORGANON & CO - NEXPLANON USE EXTENDED TO FIVE YEARSSource text: ID:nBw6MtY47aFurther company coverage: OGN.N ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2604571948","isCrawlerRequest":true}